These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26364713)

  • 1. Collective relaxation dynamics and crystallization kinetics of the amorphous Biclotymol antiseptic.
    Tripathi P; Romanini M; Tamarit JL; Macovez R
    Int J Pharm; 2015 Nov; 495(1):420-427. PubMed ID: 26364713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
    Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
    Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
    Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
    Shete G; Khomane KS; Bansal AK
    J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
    Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
    J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of α-relaxation on crystallization of amorphous celecoxib above T(g) probed by dielectric spectroscopy.
    Dantuluri AK; Amin A; Puri V; Bansal AK
    Mol Pharm; 2011 Jun; 8(3):814-22. PubMed ID: 21534589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glass transition, crystallization kinetics, and inter-conformer relaxation dynamics of amorphous mitotane and related compounds.
    Romanini M; Pérez Valmaseda A; Macovez R
    Int J Pharm; 2022 Dec; 629():122390. PubMed ID: 36379398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between molecular mobility and physical stability of amorphous itraconazole.
    Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
    Mol Pharm; 2013 Feb; 10(2):694-700. PubMed ID: 23198856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose Temperature and Anticorrelation between Recrystallization Kinetics and Molecular Relaxation Dynamics in Amorphous Morniflumate at High Pressure.
    Romanini M; Rodriguez S; Valenti S; Barrio M; Tamarit JL; Macovez R
    Mol Pharm; 2019 Aug; 16(8):3514-3523. PubMed ID: 31274326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
    Baghel S; Cathcart H; Redington W; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the relaxation dynamics of a double glass-forming antiferroelectric liquid crystal.
    Drzewicz A; Jasiurkowska-Delaporte M; Juszyńska-Gałązka E; Zając W; Kula P
    Phys Chem Chem Phys; 2021 Apr; 23(14):8673-8688. PubMed ID: 33876028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics in liquid and glassy states of non-steroidal anti-inflammatory drug: ketoprofen.
    Sailaja U; Shahin Thayyil M; Krishna Kumar NS; Govindaraj G
    Eur J Pharm Sci; 2013 May; 49(2):333-40. PubMed ID: 23563049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal Behavior and Slow Relaxation Dynamics in Amorphous Efavirenz: A Study by DSC, XRPD, TSDC, and DRS.
    Moura Ramos JJ; Piedade MFM; Diogo HP; Viciosa MT
    J Pharm Sci; 2019 Mar; 108(3):1254-1263. PubMed ID: 30391416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Dudognon E; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2016 Feb; 499(1-2):67-73. PubMed ID: 26707413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics of ethylene glycol dimethacrylate glass former: influence of different crystallization pathways.
    Viciosa MT; Correia NT; Salmerón Sánchez M; Gómez Ribelles JL; Dionísio M
    J Phys Chem B; 2009 Oct; 113(43):14196-208. PubMed ID: 19845405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility.
    Bhugra C; Rambhatla S; Bakri A; Duddu SP; Miller DP; Pikal MJ; Lechuga-Ballesteros D
    J Pharm Sci; 2007 May; 96(5):1258-69. PubMed ID: 17455303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.
    Schammé B; Couvrat N; Tognetti V; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Mol Pharm; 2018 Mar; 15(3):1112-1125. PubMed ID: 29328661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.